Empagliflozin API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Empagliflozin API Manufacturer in India

Product Overview

Empagliflozin is a synthetic sodium-glucose cotransporter-2 (SGLT2) inhibitor used as an active pharmaceutical ingredient in medicines for type 2 diabetes and other approved cardiovascular and renal indications. It works by reducing glucose reabsorption in the kidneys, thereby increasing urinary glucose excretion.

Empagliflozin is a white to yellowish, non-hygroscopic powder. It is supplied as the free-base drug substance and is chemically distinct from combination-product ingredients such as metformin hydrochloride. The exact identity, purity profile and quality requirements should be verified through the approved product specification and batch-specific Certificate of Analysis (COA).

Chemical Information

  • Product Name: Empagliflozin
  • CAS Number: 864070-44-0
  • Molecular Formula: C23H27ClO7
  • Molecular Weight: 450.91 g/mol
  • Chemical Class: C-glucoside / SGLT2 inhibitor
  • API Category: Antidiabetic pharmaceutical API
  • Chemical Name: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofuran-3-yl]oxy]phenyl]methyl]phenyl]-D-glucitol
  • Appearance: White to yellowish, non-hygroscopic powder

Pharmaceutical Applications

Empagliflozin is used in the manufacture of approved pharmaceutical products for conditions in which SGLT2 inhibition is indicated. It is also used in pharmaceutical formulation development, analytical research and quality-control activities.

Potential pharmaceutical manufacturing and development applications include:

  • Manufacture of approved Empagliflozin-containing medicines
  • Development of immediate-release oral solid dosage forms
  • Formulation compatibility and stability studies
  • Analytical method development and validation
  • Related-substance and degradation profiling
  • Pharmaceutical process development and quality control

Empagliflozin may also be used in approved combination products. Each combination must comply with its own applicable formulation and regulatory requirements.

Mechanism of Action

Empagliflozin selectively inhibits sodium-glucose cotransporter-2 (SGLT2), the principal transporter responsible for reabsorbing filtered glucose in the kidneys. Inhibition of SGLT2 reduces renal glucose reabsorption and increases urinary glucose excretion.

This mechanism lowers blood glucose through a pathway that is independent of insulin secretion. Empagliflozin also affects renal sodium handling, which contributes to its broader pharmacological effects.

Physical and Chemical Properties

Empagliflozin is a white to yellowish, non-hygroscopic powder. It is very slightly soluble in water, sparingly soluble in methanol, slightly soluble in ethanol and acetonitrile, soluble in 50% acetonitrile-water and practically insoluble in toluene.

The compound is not described as a hydrate or solvate in the cited product information. Its solid-state characteristics and any applicable polymorphic controls should be confirmed against the approved API specification.

Quality and Compliance

Empagliflozin API quality assessment may include:

  • Identification by infrared spectroscopy and chromatographic retention time
  • Assay using a validated analytical method
  • Related-substances and degradation-product profiling
  • Water content or loss on drying, as applicable
  • Residual-solvent testing
  • Residue on ignition or sulfated ash, if specified
  • Solid-state characterization
  • Stability-indicating analytical testing

The applicable test methods and numerical acceptance limits must be taken from the current approved specification and batch COA. IP compliance should only be claimed when the applicable official monograph or regulatory documentation confirms it.

Packaging and Storage

Empagliflozin should be packed in suitable, tightly closed containers that protect the material from contamination and inappropriate environmental exposure. Storage temperature, light protection and retest period should follow the approved stability data and product-specific storage instructions.

Safety and Handling

Handle Empagliflozin API in an appropriate pharmaceutical manufacturing environment. Use suitable personal protective equipment, dust-control measures and documented material-handling procedures. Avoid inhalation, ingestion, direct contact and uncontrolled environmental release. Consult the current Safety Data Sheet for hazard classification, first-aid guidance and disposal requirements.

This page concerns bulk API procurement and pharmaceutical manufacturing, not patient-use or dosing instructions.

Frequently Asked Questions

What is Empagliflozin?

Empagliflozin is an SGLT2 inhibitor used as an active ingredient in approved pharmaceutical products.

What is the CAS number of Empagliflozin?

Its CAS number is 864070-44-0.

What is the molecular formula of Empagliflozin?

Its molecular formula is C23H27ClO7.

What is the molecular weight of Empagliflozin?

Its molecular weight is approximately 450.91 g/mol.

What is the appearance of Empagliflozin API?

It is described as a white to yellowish, non-hygroscopic powder.

What is the mechanism of action of Empagliflozin?

It inhibits SGLT2 in the kidneys, reducing glucose reabsorption and increasing urinary glucose excretion.

Which tests are relevant for Empagliflozin API?

Typical quality tests include identification, assay, related substances, residual solvents, water content or loss on drying and other tests included in the approved specification.

Is Empagliflozin IP compliant?

IP compliance must be established against the current official Indian Pharmacopoeia monograph or applicable approved regulatory specification. Do not infer compliance from the product name alone.

Empagliflozin API Enquiry

For Empagliflozin API procurement, request the current product specification, batch COA, analytical method details, regulatory documentation, packaging configuration and storage requirements. Include your required quantity and intended pharmaceutical manufacturing application in your enquiry.

Detailed Specifications

Parameter Specification
Appearance White to yellowish
Identification IR and HPLC complaint
Assay (HPLC) 97.0–103.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.1%
Heavy Metals NMT 10 ppm
Solubility Very slightly soluble in water
Get Bulk Quote via WhatsApp
chatbot/chatbot.js" defer>